Related Experiment Videos
[Improved left ventricular endocardial detection by a first generation contrast agent. Effect of dose]
F Vargas1, G Hilbert, D Gruson
1Service d'information médicale, hôpital Pellegrin-Tripode, place Amélie-Raba-Léon, 33076 Bordeaux.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|March 3, 2001
Summary
Albunex contrast agent significantly improves left ventricular endocardial detection during echocardiography. Higher doses and central vein injections yielded better results, particularly for the lateral wall.
Area of Science:
- Cardiology
- Medical Imaging
- Echocardiography
Background:
- Accurate assessment of left ventricular function relies on clear endocardial border visualization.
- Standard transthoracic echocardiography (TTE) can be limited by poor endocardial identification.
Purpose of the Study:
- To evaluate the efficacy of Albunex, a contrast agent, in enhancing left ventricular endocardial detection.
- To determine the dose-effect relationship and optimal administration route for Albunex in echocardiography.
Main Methods:
- Prospective study involving 41 patients undergoing TTE.
- Comparison of standard TTE with Albunex administration at varying doses (0.1 mg/Kg, 0.2 mg/Kg) via peripheral and central veins.
- Analysis by two independent observers before the advent of second harmonic imaging.
Main Results:
- Albunex significantly improved endocardial detection compared to standard TTE (p < 0.005).
- Higher Albunex doses and central vein injections resulted in superior detection (p < 0.005).
- Lateral wall endocardial visualization showed greater improvement than the septal border.
Conclusions:
- Albunex is effective in improving left ventricular endocardial detection in echocardiography.
- The benefits are more pronounced with higher doses and central venous administration, especially for the lateral wall.
- No adverse events were reported, indicating a safe procedure.